| Tretinoin | Approved Investigational Nutraceutical | SOX7 | 83595 |
upregulated | Tretinoin results in increased expression of SOX7 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX8 | 30812 |
upregulated | Tretinoin results in increased expression of SOX8 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX9 | 6662 |
upregulated | Tretinoin results in increased expression of SOX9 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SP1 | 6667 |
upregulated | Tretinoin results in increased expression of SP1 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SP140 | 11262 |
upregulated | Tretinoin results in increased expression of SP140 mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SP4 | 6671 |
downregulated | Tretinoin results in decreased expression of SP4 mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SP7 | 121340 |
upregulated | Tretinoin results in increased expression of SP7 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SP8 | 221833 |
downregulated | Tretinoin results in decreased expression of SP8 mRNA | 7p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPARCL1 | 8404 |
downregulated | Tretinoin results in decreased expression of SPARCL1 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPATA13 | 221178 |
downregulated | Tretinoin results in decreased expression of SPATA13 mRNA | 13q12.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SPATA18 | 132671 |
upregulated | Tretinoin results in increased expression of SPATA18 mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | SPATS2L | 26010 |
upregulated | Tretinoin results in increased expression of SPATS2L mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPC25 | 57405 |
downregulated | Tretinoin results in decreased expression of SPC25 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPDYE8P | 728524 |
upregulated | Tretinoin results in increased expression of SPDYE8P mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | SPHK1 | 8877 |
downregulated | Tretinoin results in decreased expression of SPHK1 mRNA | 17q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPI1 | 6688 |
upregulated | Tretinoin results in increased expression of SPI1 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPINK2 | 6691 |
downregulated | Tretinoin results in decreased expression of SPINK2 mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | SPINK5 | 11005 |
upregulated | Tretinoin results in increased expression of SPINK5 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | SPINT1 | 6692 |
upregulated | Tretinoin results in increased expression of SPINT1 mRNA | 15q15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPINT2 | 10653 |
downregulated | Tretinoin results in decreased expression of SPINT2 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPINT2 | 10653 |
upregulated | Tretinoin results in increased expression of SPINT2 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPNS2 | 124976 |
downregulated | Tretinoin results in decreased expression of SPNS2 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPOCK1 | 6695 |
downregulated | Tretinoin results in decreased expression of SPOCK1 mRNA | 5q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPOCK3 | 50859 |
upregulated | Tretinoin results in increased expression of SPOCK3 mRNA | 4q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPON1 | 10418 |
upregulated | Tretinoin results in increased expression of SPON1 mRNA | 11p15.2 | |